Oct. 30, 2024 — The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, ...

I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

The drug works by essentially forcing our cells to "spit out" dangerous protein clumps involved in Alzheimer's.

It's a treatment long used to combat compression sickness in divers ... We are seeing an absolute effect in this, and other disorders, for Parkinson's, migraines, some even MS, neurological disorders.

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

BENGALURU: Parkinson’s disease (PD) has no cure, and the symptoms get worse as the disease progresses with the patient age.

A drug commonly used to treat glaucoma has been shown in zebrafish ... including more common diseases characterized by the ...